Allergy Immunotherapy Market

Future Market Insights

Key Insight

Injections represent 67.7% of product type sales in 2026. The allergy immunotherapy market is estimated at USD 2,427.7 million in 2026, is projected to reach USD 5,438.6 million by 2036 and is forecast to post an 8.4% CAGR between 2026 and 2036, creating an incremental opportunity of USD 3,010.9 million.

April 24, 2026

Anurag Sharma

500 Pages

Cite this Report

Allergy Immunotherapy Market

https://www.futuremarketinsights.com/reports/allergy-immunotherapy-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

ALK Abelló
Aimmune Therapeutics
Allergopharma
Allergy Therapeutics Plc
Biomay AG
HAL Allergy Group
HollisterStier Allergy
Natural Capsules Limited
Stallergenes Greer plc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Allergy Immunotherapy Market

Key Players

Similar Industry Reports